Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Grant: 5R21CA223394-02
Targeting Musashi-2 (MSI2) regulation of EGFR and HER2 in lung cancer
National Institutes of Health
Grant: 5R01CA204808-03
Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk
National Institutes of Health
Grant: 5R01CA218802-04
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
Fields of Study
Keywords
Sustainable Development Goals